Literature DB >> 7480529

Concurrent self-administration of ethanol and an alternative nondrug reinforcer in monkeys: effects of income (session length) on demand for drug.

M E Carroll1, J S Rodefer, J M Rawleigh.   

Abstract

Eight rhesus monkeys (Macaca mulata) were trained to self-administer orally delivered ethanol (8%) and saccharin (0.03 or 0.3% wt/vol) or water under concurrent fixed-ratio (FR) schedules. The FR requirement for saccharin was fixed at 32, while the FR for ethanol was varied (4, 8, 16, 32, 64 and 128) in a non-systematic order to assess demand for drug. Demand was defined as consumption plotted as a function of price (FR). Income was defined as the duration of access to available resources. Income was varied by allowing access to the concurrently available liquids 20, 60 or 180 min per day. Order of testing was counter-balanced across monkeys. Saccharin deliveries were much higher than ethanol deliveries under the 180-min income condition; however, they were lower than ethanol deliveries when income was reduced to 20 min and the ethanol FR was 4, 8 or 16. Thus, when the price of drug was relatively low, consumption of drug exceeded that of the nondrug reinforcer, and that relationship was reversed as income decreased. Saccharin deliveries sustained a proportionally greater reduction due to decreased income compared to ethanol deliveries. As income decreased from 180 to 20 min, saccharin deliveries were reduced by an average of 79.1% (across ethanol FR conditions) while ethanol deliveries were reduced by an average of 41.2 and 40.8% when concurrent saccharin or water were available, respectively; thus, drug self-administration was more resistant to income changes than saccharin. The demand for ethanol was shifted downward in a parallel fashion as income decreased.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480529     DOI: 10.1007/bf02246139

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure.

Authors:  M A Nader; W L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Behavioral economics of drug self-administration and drug abuse policy.

Authors:  S R Hursh
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

3.  Income and choice between different goods.

Authors:  D Shurtleff; F R Warren-Boulton; A Silberberg
Journal:  J Exp Anal Behav       Date:  1987-09       Impact factor: 2.468

4.  A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior.

Authors:  M E Carroll; S T Lac; S L Nygaard
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  The effects of ethanol initiation procedures on ethanol reinforced behavior in the alcohol-preferring rat.

Authors:  K Schwarz-Stevens; H H Samson; G A Tolliver; L Lumeng; T K Li
Journal:  Alcohol Clin Exp Res       Date:  1991-03       Impact factor: 3.455

6.  Concurrent phencyclidine and saccharin access: presentation of an alternative reinforcer reduces drug intake.

Authors:  M E Carroll
Journal:  J Exp Anal Behav       Date:  1985-01       Impact factor: 2.468

7.  Drinking device for rhesus monkeys.

Authors:  J E Henningfield; R A Meisch
Journal:  Pharmacol Biochem Behav       Date:  1976-05       Impact factor: 3.533

8.  Reinforcer interactions under concurrent schedules of food, water, and intravenous cocaine.

Authors:  S.I. Dworkin; S. Mirkis; J.E. Smith
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

9.  Reduction of heroin intake in baboons by an economic constraint.

Authors:  T F Elsmore; G V Fletcher; D G Conrad; F J Sodetz
Journal:  Pharmacol Biochem Behav       Date:  1980-11       Impact factor: 3.533

10.  Effects of income on drug choice in humans.

Authors:  R J DeGrandpre; W K Bickel; S A Rizvi; J R Hughes
Journal:  J Exp Anal Behav       Date:  1993-05       Impact factor: 2.468

View more
  7 in total

1.  Concurrent-chains schedules as a method to study choice between alcohol-associated conditioned reinforcers.

Authors:  Corina Jimenez-Gomez; Timothy A Shahan
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

2.  Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. cocaine self-administration in rats maintained under FR schedules.

Authors:  S D Comer; S T Lac; C L Wyvell; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

3.  Substitutability of nicotine alone and an electronic cigarette liquid using a concurrent choice assay in rats: A behavioral economic analysis.

Authors:  John R Smethells; Andrew C Harris; Danielle Burroughs; Steven R Hursh; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2018-02-05       Impact factor: 4.492

4.  Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats.

Authors:  Mary W Hulin; Michelle N Lawrence; Russell J Amato; Peter F Weed; Peter J Winsauer
Journal:  Alcohol       Date:  2015-01-06       Impact factor: 2.405

Review 5.  Behavioral economic demand as a unifying language for addiction science: Promoting collaboration and integration of animal and human models.

Authors:  Justin C Strickland; Ryan T Lacy
Journal:  Exp Clin Psychopharmacol       Date:  2020-02-27       Impact factor: 3.157

6.  Effects of a non-drug reinforcer, saccharin, on oral self-administration of phencyclidine in male and female rhesus monkeys.

Authors:  Kelly P Cosgrove; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2003-07-01       Impact factor: 4.530

7.  Ratio size and cocaine concentration effects on oral cocaine-reinforced behavior.

Authors:  M J Macenski; R A Meisch
Journal:  J Exp Anal Behav       Date:  1998-09       Impact factor: 2.468

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.